Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cardiovascular disease news

Show

From To
Too Few People With HIV Take Aspirin to Prevent Heart Attacks and Strokes

Most HIV-positive people who should be taking aspirin to prevent a heart attack or stroke are not doing so, according to a University of Alabama at Birmingham (UAB) study published online ahead of print by Clinical Infectious Diseases. In fact, fewer than one in five who met the U.S. criteria for aspirin therapy were taking advantage of the cheap, over-the-counter medication.

Published
06 September 2012
From
AIDSMeds
HIV and antiretroviral therapy increase risk of cardiovascular disease, shows meta-analysis

People with HIV have an increased risk of cardiovascular disease, and the risk is higher still for those taking antiretroviral therapy, results of a meta-analysis published in

Published
06 September 2012
By
Michael Carter
Interferon, High Blood Pressure May be Risk to Vision

People living with hepatitis C virus (HCV) and who have high blood pressure should see an eye specialist while undergoing therapy with pegylated interferon-based regimens, according to an Italian study published in the August issue of Hepatology. 

Published
23 August 2012
From
AIDSMeds
Might Aspirin Reduce Cardiovascular Risk in People With HIV?

Could daily aspirin help reduce the excessive risk of a heart attack and other health complications associated with blood clots, immune activation and inflammation in people living with HIV? A small pilot study reported Thursday, July 26, at the XIX International AIDS Conference in Washington, DC, by New York University (NYU) researchers points to the possibility.

Published
21 August 2012
From
AIDSMeds
Study Identifies Potential Causes For HIV-Associated Cardiovascular Disease

Researchers have identified microbial translocation, the leaking of bacteria from the intestine into the bloodstream that causes chronic inflammation, as a critical factor in the development of cardiovascular disease (CVD) in patients with HIV. Study results were recently published online in Blood, the Journal of the American Society of Hematology (ASH).

Published
12 July 2012
From
HIV / AIDS News From Medical News Today
ART Reduces Inflammation Overall, but Tenofovir and Abacavir Have Different Effects

Some inflammation-associated biomarkers decreased among people with HIV who started combination antiretroviral therapy (ART) regardless of regimen, but others -- including CRP and IL-6 -- were affected differently by different drug regimens, researchers reported in the July 17, 2012, issue of AIDS.

Published
10 July 2012
From
HIVandHepatitis.com
Detectable viral load and low nadir CD4 cell count increase the risk of heart attack for people with HIV

A detectable viral load, a low nadir CD4 cell count and an elevated CD8 cell count are associated with an increased risk of heart attack for people

Published
05 July 2012
By
Michael Carter
Theratechnologies sinks on HIV drug setback

The Committee for Medicinal Products for Human Use in Europe cited potential concerns for long-term users and a lack of data on cardiovascular risks as the reason for its unfavorable view of the drug, Theratechnologies said in a statement.

Published
22 June 2012
From
Reuters
Heart Trouble Early and Often in H.I.V. Patients

Mike Godfrey was 19 when he found out he had H.I.V. He was 29 when he began antiretroviral therapy. He was 43 when he had a heart attack.

Published
19 June 2012
From
New York Times
Starting HIV treatment with a CD4 cell count below 350 associated with a key marker of cardiovascular risk

Starting HIV treatment with a CD4 cell count below 350 cells/mm3 may increase the long-term risk of cardiovascular disease, US research published in AIDS suggests. Investigators found

Published
25 May 2012
By
Michael Carter

Filter by country